-
1
-
-
0019756824
-
Diphosphonates: history and mechanisms of action
-
Fleisch H. Diphosphonates: history and mechanisms of action. Metab. Bone Dis. Relat. Res. 3 (1981) 279-287
-
(1981)
Metab. Bone Dis. Relat. Res.
, vol.3
, pp. 279-287
-
-
Fleisch, H.1
-
2
-
-
0032468984
-
Bisphosphonates: mechanisms of action
-
Fleisch H. Bisphosphonates: mechanisms of action. Endocr. Rev. 19 (1998) 80-100
-
(1998)
Endocr. Rev.
, vol.19
, pp. 80-100
-
-
Fleisch, H.1
-
3
-
-
0033065233
-
Bisphosphonates: from the laboratory to the clinic and back again
-
Russell R.G.G., and Rogers M.J. Bisphosphonates: from the laboratory to the clinic and back again. Bone 25 (1999) 97-106
-
(1999)
Bone
, vol.25
, pp. 97-106
-
-
Russell, R.G.G.1
Rogers, M.J.2
-
4
-
-
0014007431
-
Enzymatic synthesis of diadenosine tetraphosphate and diadenosine triphosphate with a purified lysyl-sRNA synthetase
-
Zamecnik P.C., Stephenson M.L., Janeway C.M., and Randerath K. Enzymatic synthesis of diadenosine tetraphosphate and diadenosine triphosphate with a purified lysyl-sRNA synthetase. Biochem. Biophys. Res. Commun. 24 (1966) 91-97
-
(1966)
Biochem. Biophys. Res. Commun.
, vol.24
, pp. 91-97
-
-
Zamecnik, P.C.1
Stephenson, M.L.2
Janeway, C.M.3
Randerath, K.4
-
6
-
-
0028059006
-
Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum
-
Rogers M.J., Ji X., Russell R.G.G., Blackburn G.M., Williamson M.P., Bayless A.V., Ebetino F.H., and Watts D.J. Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum. Biochem. J. 303 (1994) 303-311
-
(1994)
Biochem. J.
, vol.303
, pp. 303-311
-
-
Rogers, M.J.1
Ji, X.2
Russell, R.G.G.3
Blackburn, G.M.4
Williamson, M.P.5
Bayless, A.V.6
Ebetino, F.H.7
Watts, D.J.8
-
7
-
-
0030601220
-
Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes
-
Rogers M.J., Brown R.J., Hodkin V., Blackburn G.M., Russell R.G.G., and Watts D.J. Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes. Biochem. Biophys. Res. Commun. 224 (1996) 863-869
-
(1996)
Biochem. Biophys. Res. Commun.
, vol.224
, pp. 863-869
-
-
Rogers, M.J.1
Brown, R.J.2
Hodkin, V.3
Blackburn, G.M.4
Russell, R.G.G.5
Watts, D.J.6
-
8
-
-
0242503684
-
New insights into the molecular mechanisms of action of bisphosphonates
-
Rogers M.J. New insights into the molecular mechanisms of action of bisphosphonates. Curr. Pharm. Des. 9 (2003) 2643-2658
-
(2003)
Curr. Pharm. Des.
, vol.9
, pp. 2643-2658
-
-
Rogers, M.J.1
-
9
-
-
0026486931
-
Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis
-
Amin D., Cornell S.A., Gustafson S.K., Needle S.J., Ullrich J.W., Bilder G.E., and Perrone M.H. Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis. J. Lipid Res. 33 (1992) 1657-1663
-
(1992)
J. Lipid Res.
, vol.33
, pp. 1657-1663
-
-
Amin, D.1
Cornell, S.A.2
Gustafson, S.K.3
Needle, S.J.4
Ullrich, J.W.5
Bilder, G.E.6
Perrone, M.H.7
-
10
-
-
13044283050
-
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
-
Fisher J.E., Rogers M.J., Halasy J.M., Luckman S.P., Hughes D.E., Masarachia P.J., Wesolowski G., Russell R.G.G., Rodan G.A., and Reszka A.A. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc. Natl. Acad. Sci. USA 96 (1999) 133-138
-
(1999)
Proc. Natl. Acad. Sci. USA
, vol.96
, pp. 133-138
-
-
Fisher, J.E.1
Rogers, M.J.2
Halasy, J.M.3
Luckman, S.P.4
Hughes, D.E.5
Masarachia, P.J.6
Wesolowski, G.7
Russell, R.G.G.8
Rodan, G.A.9
Reszka, A.A.10
-
12
-
-
0033958778
-
Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase
-
Bergstrom J.D., Bostedor R.G., Masarachia P.J., Reszka A.A., and Rodan G. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch. Biochem. Biophys. 373 (2000) 231-241
-
(2000)
Arch. Biochem. Biophys.
, vol.373
, pp. 231-241
-
-
Bergstrom, J.D.1
Bostedor, R.G.2
Masarachia, P.J.3
Reszka, A.A.4
Rodan, G.5
-
13
-
-
0036569635
-
Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway
-
Virtanen S.S., Väänänen H.K., Härkönen P.L., and Lakkakorpi P.T. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res. 62 (2002) 2708-2714
-
(2002)
Cancer Res.
, vol.62
, pp. 2708-2714
-
-
Virtanen, S.S.1
Väänänen, H.K.2
Härkönen, P.L.3
Lakkakorpi, P.T.4
-
15
-
-
0033796867
-
Synthesis of dinucleoside polyphosphates catalyzed by firefly luciferase and several ligases
-
Sillero A., and Sillero M.A.G. Synthesis of dinucleoside polyphosphates catalyzed by firefly luciferase and several ligases. Pharmacol. Ther. 87 (2000) 91-102
-
(2000)
Pharmacol. Ther.
, vol.87
, pp. 91-102
-
-
Sillero, A.1
Sillero, M.A.G.2
-
16
-
-
0033135431
-
T4 RNA ligase catalyzes the synthesis of dinucleoside polyphosphates
-
Atencia E.A., Madrid O., Sillero M.A.G., and Sillero A. T4 RNA ligase catalyzes the synthesis of dinucleoside polyphosphates. Eur. J. Biochem. 261 (1999) 802-811
-
(1999)
Eur. J. Biochem.
, vol.261
, pp. 802-811
-
-
Atencia, E.A.1
Madrid, O.2
Sillero, M.A.G.3
Sillero, A.4
-
17
-
-
0027055851
-
Metabolism of halogenated bisphosphonates by the cellular slime mould Dictyostelium discoideum
-
Rogers M.J., Russell R.G.G., Blackburn G.M., Williamson M.P., and Watts D.J. Metabolism of halogenated bisphosphonates by the cellular slime mould Dictyostelium discoideum. Biochem. Biophys. Res. Commun. 189 (1992) 414-423
-
(1992)
Biochem. Biophys. Res. Commun.
, vol.189
, pp. 414-423
-
-
Rogers, M.J.1
Russell, R.G.G.2
Blackburn, G.M.3
Williamson, M.P.4
Watts, D.J.5
-
18
-
-
0031977199
-
Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras
-
Luckman S.P., Hughes D.E., Coxon F.P., Graham R., Russell G., and Rogers M.J. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J. Bone Miner. Res. 13 (1998) 581-589
-
(1998)
J. Bone Miner. Res.
, vol.13
, pp. 581-589
-
-
Luckman, S.P.1
Hughes, D.E.2
Coxon, F.P.3
Graham, R.4
Russell, G.5
Rogers, M.J.6
|